Cue Biopharma (CUE) FCF Margin (2018 - 2025)
Cue Biopharma (CUE) recorded FCF Margin of -4.90% in Q4 2025, up 568.07 percentage points from -572.97% a year earlier and up 415.01 percentage points from the prior quarter.
Cue Biopharma (CUE) FCF Margin (2018 - 2025) Analysis & Trends
For FY2025, Cue Biopharma reported FCF Margin of -79.60%, up 312.29 percentage points from FY2024.
- Annual FCF Margin has increased for three straight years, with a five-year change of +969.41 percentage points (FY2020 to FY2025).
- Across earlier years, FCF Margin came in at -391.89% in FY2024 (+336.00 pp), -727.89% in FY2023 (+2643.76 pp), -3371.65% in FY2022 (-3105.61 pp) and -266.04% in FY2021 (+782.97 pp).
- The Q4 2025 figure is the highest quarterly FCF Margin in data going back to Q2 2018.
- On a year-over-year basis, FCF Margin rose in six of the last eight quarters, with an average year-over-year change of +624.82 percentage points.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 48914.95 percentage points in Q2 2023, against a drop of 49299.48 percentage points in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -419.92% (Q3 2025), -116.52% (Q2 2025) and -1976.72% (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.01% |
| 10 | Cue Biopharma | 121.14 Mn | 30.41 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -4.90% |
| Sep 30, 2025 | -419.92% |
| Jun 30, 2025 | -116.52% |
| Mar 31, 2025 | -1,976.72% |
| Dec 31, 2024 | -572.97% |
| Sep 30, 2024 | -225.60% |
| Jun 30, 2024 | -376.22% |
| Mar 31, 2024 | -573.03% |
| Dec 31, 2023 | -601.76% |
| Sep 30, 2023 | -371.38% |
| Jun 30, 2023 | -750.43% |
| Mar 31, 2023 | -5,793.05% |
| Dec 31, 2022 | -6,963.58% |
| Sep 30, 2022 | -10,219.12% |
| Jun 30, 2022 | -49,665.38% |
| Mar 31, 2022 | -1,160.00% |
| Dec 31, 2021 | -128.96% |
| Sep 30, 2021 | -277.24% |
| Jun 30, 2021 | -365.90% |
| Mar 31, 2021 | -801.22% |
Cue Biopharma FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=CUE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();